{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:04Z","timestamp":1790704324309,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057560","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T22:02:43Z","timestamp":1362780163000},"page":"e57560","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Substrate Compositional Variation with Tissue\/Region and Gba1 Mutations in Mouse Models\u2013Implications for Gaucher Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D. R.","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"ref1","unstructured":"Grabowski GA, Petsko GA, Kolodny EH (2010) Gaucher disease. In: Valle D, Beaudet A, Vogelstein B, Kinzler KW, Antonarakis SE <etal>et al<\/etal>.., editors. The Online Metabolic and Molecular Bases of Inherited Diseases. New York: The McGraw-Hill Companies, Inc."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"KS Hruska","year":"2008","journal-title":"Hum Mutat"},{"key":"ref3","unstructured":"Grabowski GA, Kolodny EH, Weinreb NJ, Rosenbloom BE, Prakash-Cheng A, <etal>et al<\/etal>.. (2006) Gaucher disease: Phenotypic and genetic variation. Chapter 146.1. In: Scriver CR, Sly WS, Beaudet A, Valle D, Childs B, editors. The Metabolic and Molecular Bases of Inherited Diseases. New York: McGraw-Hill."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations","volume":"281","author":"B Liou","year":"2006","journal-title":"J Biol Chem"},{"key":"ref5","first-page":"212","article-title":"Gaucher disease: molecular heterogeneity and phenotype-genotype correlations","volume":"45","author":"B Theophilus","year":"1989","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/gte.2005.9.26","article-title":"Phenotypic heterogeneity in patients with Gaucher disease and the N370S\/V394L genotype","volume":"9","author":"D Elstein","year":"2005","journal-title":"Genet Test"},{"key":"ref7","first-page":"523","article-title":"Quantity and fatty acyl composition of the glycosphingolipids of Gaucher spleen","volume":"80","author":"TT Kuske","year":"1972","journal-title":"J Lab Clin Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-2275(20)39063-5","article-title":"The structure of cerebrosides in Gaucher\u2019s disease","volume":"1","author":"GV Marinetti","year":"1960","journal-title":"J Lipid Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00690463","article-title":"Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies","volume":"65","author":"NG Conradi","year":"1984","journal-title":"Acta Neuropathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease","volume":"39","author":"O Nilsson","year":"1982","journal-title":"J Neurochem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)38985-9","article-title":"Lipids of the Spleen in Gaucher\u2019s Disease","volume":"6","author":"WD Suomi","year":"1965","journal-title":"J Lipid Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0006-291X(72)90381-6","article-title":"Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase","volume":"48","author":"T Miyatake","year":"1972","journal-title":"Biochem Biophys Res Commun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0006-291X(73)90916-9","article-title":"Deficiency of glucosylsphingosine: beta-glucosidase in Gaucher disease","volume":"54","author":"SS Raghavan","year":"1973","journal-title":"Biochem Biophys Res Commun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0005-2760(82)90272-7","article-title":"The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher\u2019s disease","volume":"712","author":"O Nilsson","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1399-0004.1985.tb00229.x","article-title":"Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants","volume":"27","author":"O Nilsson","year":"1985","journal-title":"Clin Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3","volume":"14","author":"UH Schueler","year":"2003","journal-title":"Neurobiol Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/00006450-200008000-00018","article-title":"Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation","volume":"48","author":"E Orvisky","year":"2000","journal-title":"Pediatr Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"YH Xu","year":"2003","journal-title":"Am J Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/hmg\/ddp531","article-title":"Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse","volume":"19","author":"Y Sun","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex Vivo and in Vivo Effects of Isofagomine on Acid beta-Glucosidase Variants and Substrate Levels in Gaucher Disease","volume":"287","author":"Y Sun","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation","volume":"278","author":"Y Sun","year":"2003","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid {beta}-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Y Sun","year":"2005","journal-title":"J Lipid Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Y Sun","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher\u2019s disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"VLJ Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0004.1982.tb01445.x","article-title":"Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III","volume":"22","author":"O Nilsson","year":"1982","journal-title":"Clin Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.1998.tb09667.x","article-title":"Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell","volume":"845","author":"K Sandhoff","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2005.06.010","article-title":"Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers","volume":"362","author":"K Michelin","year":"2005","journal-title":"Clin Chim Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","article-title":"Characterization of human glucocerebrosidase from different mutant alleles","volume":"266","author":"T Ohashi","year":"1991","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/mgme.2000.3035","article-title":"Fate and sorting of acid beta-glucosidase in transgenic mammalian cells","volume":"70","author":"T Leonova","year":"2000","journal-title":"Mol Genet Metab"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1073\/pnas.96.16.9142","article-title":"A vital role for glycosphingolipid synthesis during development and differentiation","volume":"96","author":"T Yamashita","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/glia.20930","article-title":"Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice","volume":"58","author":"L Saadat","year":"2010","journal-title":"Glia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.1073\/pnas.0500893102","article-title":"Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth","volume":"102","author":"R Jennemann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"E Orvisky","year":"2002","journal-title":"Mol Genet Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1015137917508","article-title":"Glycolipid analysis of different tissues and cerebrospinal fluid in type II Gaucher disease","volume":"25","author":"R Gornati","year":"2002","journal-title":"J Inherit Metab Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T17:37:21Z","timestamp":1644514641000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057560"}},"subtitle":[],"editor":[{"given":"Leah J.","family":"Siskind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,8]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057560","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,8]]}}}